These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 21849906)
1. Do serum angiopoietin-1, angiopoietin-2, and their receptor Tie-2 and 4G/5G variant of PAI-1 gene have a role in the pathogenesis of preeclampsia? Kamal M; El-Khayat W J Investig Med; 2011 Oct; 59(7):1147-50. PubMed ID: 21849906 [TBL] [Abstract][Full Text] [Related]
2. Maternal serum angiopoietin-1 and -2 and tie-2 in early pregnancy ending in preeclampsia or intrauterine growth retardation. Leinonen E; Wathén KA; Alfthan H; Ylikorkala O; Andersson S; Stenman UH; Vuorela P J Clin Endocrinol Metab; 2010 Jan; 95(1):126-33. PubMed ID: 19875484 [TBL] [Abstract][Full Text] [Related]
3. Plasma markers of angiogenesis in pregnancy induced hypertension. Nadar SK; Karalis I; Al Yemeni E; Blann AD; Lip GY Thromb Haemost; 2005 Nov; 94(5):1071-6. PubMed ID: 16363251 [TBL] [Abstract][Full Text] [Related]
4. Association between plasminogen activator inhibitor 1 gene polymorphisms and preeclampsia. Fabbro D; D'Elia AV; Spizzo R; Driul L; Barillari G; Di Loreto C; Marchesoni D; Damante G Gynecol Obstet Invest; 2003; 56(1):17-22. PubMed ID: 12867763 [TBL] [Abstract][Full Text] [Related]
5. Increase of serum angiopoietin-2 during pregnancy is suppressed in women with preeclampsia. Hirokoshi K; Maeshima Y; Kobayashi K; Matsuura E; Sugiyama H; Yamasaki Y; Masuyama H; Hiramatsu Y; Makino H Am J Hypertens; 2005 Sep; 18(9 Pt 1):1181-8. PubMed ID: 16182107 [TBL] [Abstract][Full Text] [Related]
6. The 4G/5G polymorphism of the plasminogen activator inhibitor-1 gene is associated with severe preeclampsia. Yamada N; Arinami T; Yamakawa-Kobayashi K; Watanabe H; Sohda S; Hamada H; Kubo T; Hamaguchi H J Hum Genet; 2000; 45(3):138-41. PubMed ID: 10807538 [TBL] [Abstract][Full Text] [Related]
7. [Correlation of angiopoietin-2 and angiopoietin-2 receptor expressions in serum and placenta with preeclampsia]. Wang LJ; Chen WP; Peng W; Xu L; Sui AH; Ye YH Zhonghua Fu Chan Ke Za Zhi; 2011 Mar; 46(3):167-71. PubMed ID: 21575447 [TBL] [Abstract][Full Text] [Related]
8. Abnormal angiopoietins 1&2, angiopoietin receptor Tie-2 and vascular endothelial growth factor levels in hypertension: relationship to target organ damage [a sub-study of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT)]. Nadar SK; Blann A; Beevers DG; Lip GY J Intern Med; 2005 Oct; 258(4):336-43. PubMed ID: 16164572 [TBL] [Abstract][Full Text] [Related]
9. [Relationship between the 4G/5G polymorphism of the plasminogen activator inhibitor-1 gene and the pathogenesis of pregnancy-induced hypertension syndrome]. Guan LX; Du XY; Wang JX; Wang RL; Wu ZL; Jiang H Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2004 Apr; 21(2):173-5. PubMed ID: 15079805 [TBL] [Abstract][Full Text] [Related]
10. Plasminogen activator inhibitor-1 4G/5G polymorphism in breast cancer patients and its association with tissue PAI-1 levels and tumor severity. Castelló R; España F; Vázquez C; Fuster C; Almenar SM; Aznar J; Estellés A Thromb Res; 2006; 117(5):487-92. PubMed ID: 15907980 [TBL] [Abstract][Full Text] [Related]
11. The prevalence of 4G/5G polymorphism of plasminogen activator inhibitor-1 (PAI-1) gene in central serous chorioretinopathy and its association with plasma PAI-1 levels. Sogutlu Sari E; Yazici A; Eser B; Erol MK; Kilic A; Ermis SS; Koytak A; Akşit H; Yakut T Cutan Ocul Toxicol; 2014 Dec; 33(4):270-4. PubMed ID: 24446892 [TBL] [Abstract][Full Text] [Related]
13. Association of PAI-1 4G/5G and -844G/A gene polymorphism and changes in PAI-1/tPA levels in stroke: a case-control study. Saidi S; Slamia LB; Mahjoub T; Ammou SB; Almawi WY J Stroke Cerebrovasc Dis; 2007; 16(4):153-9. PubMed ID: 17689411 [TBL] [Abstract][Full Text] [Related]
14. Correlation between plasminogen activator inhibitor-1 4G/5G polymorphism and pre-eclampsia: an appraisal. Wiwanitkit V Arch Gynecol Obstet; 2006 Mar; 273(6):322-4. PubMed ID: 16502012 [TBL] [Abstract][Full Text] [Related]
15. The 4G/5G sequence polymorphism in the promoter of plasminogen activator inhibitor-1 (PAI-1) gene: relationship to plasma PAI-1 level in venous thromboembolism. Stegnar M; Uhrin P; Peternel P; Mavri A; Salobir-Pajnic B; Stare J; Binder BR Thromb Haemost; 1998 May; 79(5):975-9. PubMed ID: 9609232 [TBL] [Abstract][Full Text] [Related]
16. Significant decrease in maternal serum concentrations of angiopoietin-1 and -2 after delivery. Keikkala E; Hytinantti T; Wathén KA; Andersson S; Vuorela P Acta Obstet Gynecol Scand; 2012 Aug; 91(8):917-22. PubMed ID: 22583143 [TBL] [Abstract][Full Text] [Related]
17. Relationship between gene polymorphism of the PAI-1 promoter and myocardial infarction. Fu L; Jin H; Song K; Zhang C; Shen J; Huang Y Chin Med J (Engl); 2001 Mar; 114(3):266-9. PubMed ID: 11780311 [TBL] [Abstract][Full Text] [Related]
18. Association of PAI-1 4G/5G and -844G/A gene polymorphisms and changes in PAI-1/tissue plasminogen activator levels in myocardial infarction: a case-control study. Abboud N; Ghazouani L; Saidi S; Ben-Hadj-Khalifa S; Addad F; Almawi WY; Mahjoub T Genet Test Mol Biomarkers; 2010 Feb; 14(1):23-7. PubMed ID: 19929406 [TBL] [Abstract][Full Text] [Related]
19. Influence of the 4G/5G PAI-1 genotype on angiotensin II-stimulated human endothelial cells and in patients with hypertension. Roncal C; Orbe J; Rodriguez JA; Belzunce M; Beloqui O; Diez J; Páramo JA Cardiovasc Res; 2004 Jul; 63(1):176-85. PubMed ID: 15194475 [TBL] [Abstract][Full Text] [Related]
20. Plasma angiopoietin-1, angiopoietin-2 and Tie-2 in breast and prostate cancer: a comparison with VEGF and Flt-1. Caine GJ; Blann AD; Stonelake PS; Ryan P; Lip GY Eur J Clin Invest; 2003 Oct; 33(10):883-90. PubMed ID: 14511360 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]